Exceptional Response to Olaparib: A Case Report of Metastatic Esophageal Squamous Cell Carcinoma in a Patient With Fanconi Anemia, Germline <i>FANCA</i> Mutation, and Somatic <i>BRCA2</i> Mutations-Reference-Cited by-同舟云学术

Exceptional Response to Olaparib: A Case Report of Metastatic Esophageal Squamous Cell Carcinoma in a Patient With Fanconi Anemia, Germline FANCA Mutation, and Somatic BRCA2 Mutations

Published:2023-09 Issue:7 Volume: Page:
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Haggstrom Lucy R.¹²^ORCID,Tucker Kathy²³⁴^ORCID,Williams Rachel²³⁴^ORCID,Nelson Adam⁵,Walsh Rebecca⁶,Brungs Daniel¹⁷,Aghmesheh Morteza¹²⁷^ORCID

Affiliation:

1. Illawarra Cancer Care Centre, Wollongong Hospital, Wollongong, NSW, Australia

2. Nelune Cancer Care Centre, Prince of Wales Hospital, Randwick, NSW, Australia

3. School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia

4. Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, NSW, Australia

5. Sydney Children's Hospital, Randwick, NSW, Australia

6. NSW Health Pathology Genetics Laboratory, Randwick, NSW, Australia

7. Graduate School of Medicine, University of Wollongong, Wollongong, NSW, Australia

Abstract

Exceptional response to olaparib in a case with Fanconi anemia and metastatic esophageal carcinoma

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.23.00221

Reference21 articles.

1. Fanconi anaemia

2. Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer

3. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing

4. Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

5. Genotype-phenotype associations in Fanconi anemia: A literature review

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study;Journal of Hematology & Oncology;2024-04-29